Nisa Investment Advisors LLC Purchases 835 Shares of Avantor, Inc. (NYSE:AVTR)

Nisa Investment Advisors LLC increased its position in Avantor, Inc. (NYSE:AVTR) by 69.6% during the third quarter, Holdings Channel.com reports. The firm owned 2,035 shares of the company’s stock after buying an additional 835 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Avantor were worth $53,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of AVTR. Versant Capital Management Inc boosted its stake in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after buying an additional 1,391 shares during the last quarter. UMB Bank n.a. purchased a new position in shares of Avantor during the third quarter valued at approximately $49,000. GAMMA Investing LLC raised its position in Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after buying an additional 1,285 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its position in Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after buying an additional 3,700 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on AVTR shares. Stifel Nicolaus upped their target price on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Royal Bank of Canada reiterated an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. UBS Group cut their target price on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th. Wells Fargo & Company decreased their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, TD Cowen boosted their price objective on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $27.57.

Avantor Trading Down 1.7 %

Shares of Avantor stock opened at $22.59 on Friday. The stock has a market capitalization of $15.37 billion, a P/E ratio of 49.11, a P/E/G ratio of 2.73 and a beta of 1.35. Avantor, Inc. has a 52-week low of $18.08 and a 52-week high of $28.00. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The stock’s 50-day simple moving average is $24.91 and its 200 day simple moving average is $24.12.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.